ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ballas, S.
Right arrow Articles by Delengowski, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ballas, S.
Right arrow Articles by Delengowski, A
Annals of Clinical and Laboratory Science, Vol 23, Issue 5, 358-361
Copyright © 1993 by Association of Clinical Scientists


Articles

Pain measurement in hospitalized adults with sickle cell painful episodes

SK Ballas and A Delengowski

The intensity, spatial distribution, and description of pain during the evolution of painful crises were studied in 23 hospitalized adult patients with sickle cell anemia during 60 acute painful episodes. The 10 cm Visual Analog Scale was used to measure the intensity of pain. The average pain severity score upon admission was 9.5 +/- 0.63 (mean +/- SD) and upon discharge was 4.8 +/- 0.97. The dose or frequency of administering narcotic analgesics was reduced when the daily score of pain decreased by 2 or more on the scale. Painful areas of the body most frequently affected included the back, legs, knees, arms, chest, and abdomen in descending order. The words most often selected to describe the pain were throbbing, sharp, dull, and stabbing. Our data indicate that: (1) the use of a visual analog scale is feasible in hospitalized adult patients with sickle cell painful crisis; (2) the application of this scale is clinically useful in the titration of analgesics during crises; and (3) the use of this scale may be utilized to assist in the discharge planning of these patients.


This article has been cited by other articles:


Home page
JAMAHome page
E. P. Orringer, J. F. Casella, K. I. Ataga, M. Koshy, P. Adams-Graves, L. Luchtman-Jones, T. Wun, M. Watanabe, F. Shafer, A. Kutlar, et al.
Purified Poloxamer 188 for Treatment of Acute Vaso-occlusive Crisis of Sickle Cell Disease: A Randomized Controlled Trial
JAMA, November 7, 2001; 286(17): 2099 - 2106.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the Association of Clinical Scientists.